Discloses impairment on Volkswagen, Porsche AG stakes Loss after tax of around 20 bln eur for 2024 Full annual results scheduled for March 26 Porsche SE withdrew its outlook for after-tax profit ...

908 Devices' stock surged after announcing a $70 million desktop portfolio sale, doubling its cash position and improving financial stability. The company will now focus on its handheld device ...

908 Devices sold its desktop portfolio to Repligen for $70 million, reducing $20 million in annual operating losses. 908 Devices expects 2025 revenue of $53 million-$55 million, with EBITDA ...

The company said, “908 Devices (MASS) expects full year 2025 revenues from continuing operations of $53 million to $55 million, representing 11% to 15% growth compared to 2024 revenue from ...

According to Autocar's sources, the next iteration of the Dakar is currently under development at Porsche's Weissach engineering facility and will join the refreshed 911 lineup in the near future.

On Tuesday, Repligen Corporation (NASDAQ:RGEN) purchased 908 Devices Inc.’s (NASDAQ:MASS) desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications.

908 Devices Inc. (MASS) reported a notable 31% year-over-year increase in revenue for the fourth quarter of 2024, reaching $18.8 million. This performance significantly surpassed market expectations.

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical analysis, today announced it will report financial results for the fourth quarter ...

Porsche has been spotted testing an electric 718 Cayman Expected to debut in late 2026, it will trail an electric 718 Boxster by about a year The gas-powered 718 Boxster and Cayman end production ...

NJ Top Docs has reviewed and approved Dr. Rajesh Pandey, Dr. Irina Raklyar and Dr. Alan Zalkowitz of Kayal Rheumatology Center for 2025. BERKELEY HEIGHTS, NJ, UNITED STATES, March 7, 2025 ...